Accession Number:

ADA639218

Title:

Investigation of Allegations of the Use of Mind-Altering Drugs to Facilitate Interrogations of Detainees

Descriptive Note:

Corporate Author:

OFFICE OF THE INSPECTOR GENERAL (DEPARTMENT OF DEFENSE) ARLINGTON VA

Personal Author(s):

Report Date:

2009-09-23

Pagination or Media Count:

40.0

Abstract:

What We Did. In response to a tasking to the Inspectors General of DoD and the Central Intelligence Agency from Senators Biden, Hagel, and Levin, we investigated allegations that mind-altering drugs were administered to detainees to facilitate interrogation at DoD interrogation facilities. The Central Intelligence Agency Inspector General conducted a separate investigation of its interrogation facilities. What We Found. We did not substantiate allegations made by or on behalf of present and former detainees that tl1ey had been administered mind-altering drugs for interrogation purposes at DoD interrogation facilities. We found no evidence that DoD authorized the use of mind altering drugs to facilitate interrogation. We did, however, note that some detainees received ongoing medication with psychoactive drugs for treatment of diagnosed medical conditions which could impair an individuals ability to provide accurate information. We also observed that certain detainees, diagnosed as having serious mental health conditions and being treated with psychoactive medications on a continuing basis, were interrogated.

Subject Categories:

  • Sociology and Law
  • Pharmacology
  • Military Intelligence

Distribution Statement:

APPROVED FOR PUBLIC RELEASE